Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway.
Jie MaoXiaocui ZhangChunxiang WangSuying Peng
Published in: Clinical and experimental hypertension (New York, N.Y. : 1993) (2024)
Irisin administration lowered salt-sensitive hypertension through regulating RAC1-MR signaling via activation of AMPK, which may be a promising therapeutic approach for salt-sensitive hypertension.